Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationStem Cell TransplantationImmunosuppressive AgentsRemission InductionHematologic NeoplasmsTreatment OutcomeGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTime FactorsBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidStem CellsImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraT-LymphocytesHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCell DifferentiationCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectFollow-Up StudiesGraft vs Leukemia EffectCytarabineLeukocyte CountSurvival RateCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorSpleenBone ResorptionMelphalanMice, Inbred BALB CFlow CytometryDisease-Free SurvivalEtoposideCells, CulturedMultiple MyelomaLymphomaAntigens, CD34Fatal OutcomeMice, KnockoutHodgkin DiseaseCell TransplantationCord Blood Stem Cell TransplantationPrognosisInfection